MindPath Pharma Consulting provides specialized strategic consulting across the full spectrum of drug development and digital health — with particular depth in CNS, psychiatry, and addiction medicine.
End-to-end clinical R&D planning from target validation through regulatory submission, with indication-specific protocol design grounded in the mechanism of action and patient population.
Key Capabilities
Deep domain expertise across substance use disorders, major depressive disorder, PTSD, anxiety disorders, and treatment-resistant conditions — from novel mechanism evaluation to pivotal trial design.
Key Capabilities
Strategic consulting for prescription digital therapeutics (PDTs) and software as a medical device (SaMD), including regulatory pathway selection, clinical evidence generation, and reimbursement planning.
Key Capabilities
FDA and EMA interaction planning, briefing document preparation.
CRO selection, site strategy, enrollment optimization, and data quality governance.
R&D narrative development, diligence support, fundraising deck strategy, and board-level clinical updates.
Biomarker-driven development strategy, preclinical-to-clinical translation, and proof-of-concept study design.
Publication planning, KOL engagement, medical education, scientific storytelling, and advisory board management.
Line extensions, formulation strategy, indication expansion, and post-approval commitments.
Adaptive designs, Bayesian approaches, seamless Phase I/II/III, and master protocols — to generate decisive, regulator-ready evidence.
Real-world data, health economics, and outcomes research to complement RCT packages — strengthening regulatory submissions and payer dossiers.
MindPath is a parallel advisory track alongside ongoing C-suite work. Engagements are accepted when capacity allows, and are screened for conflicts.
Protocol, IND, or FDA briefing — a bounded deliverable for a critical decision point.
Ongoing senior development leadership, calibrated to program stage and available capacity.
Independent clinical and regulatory read of a CNS, psychiatry, or digital therapeutics asset.
Reach out to discuss how MindPath can support your program — from a focused strategic review to a long-term engagement as a senior development partner.
Start a Conversation